Least developed countries (LDCs) generally enjoy some exemptions under the WTO TRIPS Agreement. Despite these exemptions, patents continue to pose a major challenge to access to affordable medicines in the East African Community (EAC), especially with respect to the HIV/AIDS pandemic.
The EAC is a regional economic bloc made up of six states, with five of the member states currently ranked as LDCs by the United Nations. This article argues that the implementation of the patent protection standards following the model adopted in the Trans-Pacific Partnership is likely to
further exacerbate the access to medicines conundrum of the EAC.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Access to medicines;
Document Type: Research Article
Graduate School of Business and Law, RMIT University, Melbourne, Australia
Department of Business Law, Faculty of Law, University of Ilorin, Ilorin, Nigeria
School of Law, Robert Gordon University, Aberdeen, Scotland
Publication date: March 4, 2019
More about this publication?